Amlodipine And Atorvastatin Tablet, Coated
Product Images NDC 66993-271

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Amlodipine And Atorvastatin (NDC 66993-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Amlodipine 01)

Chemical structure diagram of Amlodipine, one of the active ingredients in the combination drug Amlodipine and Atorvastatin.*

FDA Label Image

Chemical Structure (Amlodipine 02)

Chemical structure diagram of the active ingredient Amlodipine and Atorvastatin, showing the molecular arrangement including phenyl groups, fluorine, calcium ion, and water molecules.*

FDA Label Image

Figure 1 (Amlodipine 03)

A line graph comparing event rates over time (in months) between Amlodipine and placebo groups, showing a lower event rate for Amlodipine. The graph includes a hazard ratio of 0.691, 95% confidence interval (0.54, 0.88) and a p-value of 0.003, with numbers at risk noted below the x-axis.*

FDA Label Image

Figure 2 (Amlodipine 04)

A forest plot showing hazard ratios with 95% confidence intervals for different patient subgroups comparing Amlodipine and placebo. Subgroups include overall patients, age groups (<65 and ≥65), gender, baseline sitting systolic blood pressure (SBP), baseline vessel disease type, baseline vessels with stenosis, and PCI-stent strata. The x-axis represents the hazard ratio from 0 to 2, with a vertical line at 1 indicating no difference. Most hazard ratios favor Amlodipine as indicated on the left side of the plot.*

FDA Label Image

Figure 3 (Amlodipine 05)

A line graph showing cumulative incidence percentage over 3.5 years comparing atorvastatin and placebo groups. The solid line represents atorvastatin with a lower cumulative incidence than the placebo's dashed line. Hazard ratio (HR) is 0.64 with a 95% confidence interval of 0.50 to 0.83, and a p-value of 0.0005, indicating statistical comparison between the two groups.*

FDA Label Image

Figure 4 (Amlodipine 06)

A cumulative hazard curve chart comparing Atorvastatin with placebo over a follow-up period of up to 4 years. The solid line represents Atorvastatin, while the dashed line represents placebo. The chart notes a hazard ratio (HR) of 0.63 with p=0.001, indicating relative risk over time.*

FDA Label Image

Figure 5 (Amlodipine 07)

A line chart comparing the percentage of subjects experiencing a major cardiovascular event over time between two atorvastatin dose groups, 10 mg (dashed line) and 80 mg (solid line), measured in years up to 5 years. The chart includes a hazard ratio of 0.78 (0.69-0.89) with a p-value of 0.0002, indicating statistical analysis results.*

FDA Label Image

Principal Display Panel (2.5 mg/10 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin Tablets 2.5 mg/10 mg by Prasco Laboratories. The label indicates a package of 30 coated tablets, includes storage instructions at 25°C with permitted excursions, dosage instructions to see prescribing information, and manufacturing origin in Germany. The label also features the NDC 66993-263-30 and barcode details.*

FDA Label Image

Principal Display Panel (2.5 mg/20 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin Tablets 2.5 mg/20 mg by Prasco Laboratories, distributed from Mason, OH. The label indicates it contains 30 oral coated tablets, includes storage instructions at 25°C (77°F), dosage and use directions referencing prescribing information, and states the product is made in Germany.*

FDA Label Image

Principal Display Panel (2.5 mg/40 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin tablets, coated, strength 2.5 mg/40 mg, containing 30 tablets per container. The label includes dosage storage instructions, Prasco Laboratories as the distributor, and states the product is made in Germany. The label also features a barcode, NDC 66993-265-30, and Prasco Laboratories branding.*

FDA Label Image

Principal Display Panel (5 mg/10 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin Tablets, 5 mg/10 mg, oral coated tablets in a bottle of 30 tablets. The label shows the Prasco Laboratories logo and states the medication is prescription only. Storage instructions and dosage unit content details for amlodipine and atorvastatin are included. Manufactured in Germany and distributed by Prasco Laboratories, Mason, OH.*

FDA Label Image

Principal Display Panel (5 mg/20 mg Tablet Bottle Label)

Amlodipine and Atorvastatin Tablets 5 mg/20 mg coated tablets label from Prasco Laboratories. The label shows storage information, dosage note, and tablet content details. It states 30 tablets per package, includes NDC 66993-267-30, and indicates the product is made in Germany with Rx only status.*

FDA Label Image

Principal Display Panel (5 mg/40 mg Tablet Bottle Label)

Amlodipine and Atorvastatin Tablets 5 mg/40 mg blister pack label by Prasco Laboratories. The label includes storage instructions, a barcode, NDC 66993-268-30, and indicates the package contains 30 coated tablets. Manufactured in Germany and distributed by Prasco Laboratories, Mason, OH.*

FDA Label Image

Principal Display Panel (5 mg/80 mg Tablet Bottle Label)

Amlodipine and Atorvastatin Tablets 5 mg/80 mg coated tablets packaging label from Prasco Laboratories. The label shows 30 tablets, storage instructions, dosage use reference, and contains barcode and GTIN information. It indicates the product is Rx only and made in Germany.*

FDA Label Image

Principal Display Panel (10 mg/10 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin tablets, coated, with strength 10 mg/10 mg, distributed by Prasco Laboratories. The label includes storage instructions at 25°C with permitted excursions, dosage and use note to see prescribing information, and notes each tablet contains specific amounts of amlodipine and atorvastatin. The label also shows NDC 66993-270-30, package count of 30 tablets, a barcode, and manufacturing origin as Germany.*

FDA Label Image

Principal Display Panel (10 mg/20 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin Tablets 10 mg/20 mg by Prasco Laboratories. The label indicates storage instructions, dosage information, and manufacturing details, including that the product is made in Germany and distributed by Prasco Laboratories in Mason, OH. The label also features a barcode and lot, expiration, and serial number fields.*

FDA Label Image

Principal Display Panel (10 mg/40 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin Tablets, 10 mg/40 mg strength, manufactured by Prasco Laboratories. The label includes storage instructions, dosage information, and distributor details, indicating 30 tablets per package. The label is primarily white with green, black, purple, and red text and features barcodes and regulatory codes.*

FDA Label Image

Principal Display Panel (10 mg/80 mg Tablet Bottle Label)

Label for Amlodipine and Atorvastatin Tablets 10 mg/80 mg by Prasco Laboratories. The label states the product contains 30 coated tablets, is prescription only, and includes storage information at 25°C with permitted excursions. The label specifies the tablet strengths and the equivalent active ingredient amounts, with manufacturing in Germany and distribution from Mason, OH, USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.